Disc Medicine earns a Strong Buy rating as bitopertin advances for EPP/XLP, with FDA review fast-tracked and strong funding.

Jefferies, Leerink Partners, Morgan Stanley and Cantor are acting as joint book-running managers for the offering. Wedbush PacGrow and H.C. Wainwright & Co. are acting as co-managers for the offering.

Here are six key updates from Newport Beach, Calif.-based DISC Sports & Spine Center so far in 2025: 1. Twenty physicians with Newport Beach, Calif.-based DISC Sports & Spine Center were honored by ...

Disc Medicine (IRON) outlined its recent pipeline and operational progress and strategic priorities for the rest of 2025 and 2026. “2025 has been ...